Becton Dickinson & Co. header image

Becton Dickinson & Co.

BDX

Equity

ISIN null / Valor 912061

New York Stock Exchange, Inc (2026-04-29)
USD 145.45-0.47%

Becton Dickinson & Co.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Becton Dickinson & Co. (BD) is a long-established, publicly traded medical technology company headquartered in Franklin Lakes, New Jersey, that designs, manufactures and sells a broad range of medical devices, instrument systems and diagnostic products for healthcare institutions, clinical laboratories, life sciences researchers and pharmaceutical manufacturers. Its offerings include needles and syringes, infusion and medication-delivery systems, catheter and vascular access devices, prefillable drug-delivery systems and related pharmaceutical manufacturing services, as well as diagnostic instruments, specimen collection and preanalytical systems and reagents used in clinical and molecular diagnostics. BD operates globally across multiple business units that serve hospitals, outpatient facilities, labs and biopharma customers, combining product sales with service and technical support for clinical and research workflows.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-26.9%1Y
-43.4%3Y
-41.9%5Y

Performance

37.2%1Y
26.8%3Y
24.7%5Y

Volatility

Market cap

54176 M

Market cap (USD)

Daily traded volume (Shares)

3,111,466

Daily traded volume (Shares)

1 day high/low

227.8 / 225.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 18.38
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.97%USD 17.94
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.88%EUR 366.00
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.78%CHF 3.64
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%USD 21.82
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.40%USD 24.96
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%EUR 24.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.11%USD 83.09
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.25%USD 67.51
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.89%USD 3.89